Bard Financial Services’s DexCom DXCM Stock Holding History

Bard Financial Services’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,700	Closed	-$236K	–	227
2024 Q1	$236K	Hold	1,700	–	–	0.03%	203
2023 Q4	$211K	Buy	+1,700	New	+$174K	0.02%	212
2023 Q3	–	Sell	-2,000	Closed	-$257K	–	246
2023 Q2	$257K	Hold	2,000	–	–	0.02%	268
2023 Q1	$232K	Sell	2,000 -225	-10%	-$25.2K	0.02%	281
2022 Q4	$252K	Buy	+2,225	New	+$244K	0.02%	264
2022 Q2	–	Sell	-2,200	Closed	-$281K	–	295
2022 Q1	$281K	Hold	2,200	–	–	0.02%	247
2021 Q4	$295K	Sell	2,200 -100	-4%	-$14.4K	0.02%	236
2021 Q3	$314K	Sell	2,300 -200	-8%	-$25.2K	0.03%	222
2021 Q2	$267K	Hold	2,500	–	–	0.02%	230
2021 Q1	$225K	Hold	2,500	–	–	0.02%	237
2020 Q4	$231K	Buy	+2,500	New	+$223K	0.02%	234

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bard Financial Services's DXCM Position: Q2 2024 in Review

Bard Financial Services sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,700 shares — an estimated $236K sold.

Bard Financial Services first reported a position in DXCM in Q4 2020 and held it in 11 quarters. The position peaked at $314K in Q3 2021. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

Bard Financial Services reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
Bard Financial Services sold 1,700 DexCom shares in Q2 2024, an estimated $236K.
Bard Financial Services first reported a position in DexCom in Q4 2020 and held it in 11 quarters.
Bard Financial Services's DexCom position peaked at $314K in Q3 2021.
999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Bard Financial Services's 13F filing for Q2 2024, filed 9 Jul 2024.